Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer

por Zanvit, Peter, van Dyk, Dewald, Fazenbaker, Christine, McGlinchey, Kelly, Luo, Weichuan, Pezold, Jessica M., Meekin, John, Chang, Chien-ying, Carrasco, Rosa A., Breen, Shannon, Cheung, Crystal Sao-Fong, Endlich-Frazier, Ariel, Clark, Benjamin, Chu, Nina J., Vantellini, Alessio, Martin, Philip L., Hoover, Clare E., Riley, Kenesha, Sweet, Steve M., Chain, David, Kim, Yeoun Jin, Tu, Eric, Harder, Nathalie, Phipps, Sandrina, Damschroder, Melissa, Gilbreth, Ryan N., Cobbold, Mark, Moody, Gordon, Bosco, Emily E.
Publicado 2023